Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

European approval for Fosrenol delayed

Sep. 18, 2002

Research findings support use of KRP-197 for overactive bladder

Sep. 18, 2002

Sustained beneficial effects reported for tadalafil in men with ED

Sep. 18, 2002

Chinese research demonstrates efficacy and safety of epristeride for BPH

Sep. 16, 2002

Pharmacokinetics, efficacy and safety of tadalafil discussed at meeting in Stockholm

Sep. 16, 2002

Clinical results for dutasteride in the treatment of BPH reported at SIU congress

Sep. 16, 2002

Novel PDE5 inhibitors in the Eisai pipeline

Sep. 12, 2002

Potential new treatment option for bladder overactivity: the NK2 antagonist M-274773

Sep. 12, 2002

Rho/Rho kinase pathway involved in spontaneous myogenic tone of isolated pig urethra

Sep. 9, 2002

NS-8 reverses bladder hyperactivity in rats without affecting blood pressure or heart rate

Sep. 9, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...